Showing results (251-260 of 275) with videos related to
Sort By:
Pageof 28
Age and Ageing|October 30, 2016
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopeniaCharlotte Beaudart, Mark Edwards, Charlotte Moss, et al.Oncotarget|November 5, 2017
Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteinsLili Cai, Jianbo Zhang, Renying Zhu, et al.Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|September 14, 2024
Survival of the fastest? A descriptive analysis of severely injured trauma patients primarily admitted or secondarily transferred to major trauma centers in a Danish inclusive trauma systemThea Palsgaard Møller, Josefine Tangen Jensen, Roar Borregaard Medici, et al.BMJ Open|May 11, 2023
Feasibility randomised controlled trial of online group Acceptance and Commitment Therapy for Functional Cognitive Disorder (ACT4FCD)Norman Poole, Sarah Cope, Serena Vanzan, et al.Plant Biotechnology Journal|June 15, 2013
Comparative genomics analysis in Prunoideae to identify biologically relevant polymorphismsTyson Koepke, Scott Schaeffer, Artemus Harper, et al.Journal of Sleep Research|November 15, 2023
Sleepiness and comorbid sleep disorders in functional motor disorders: a comparative study with central hypersomniaJiří Nepožitek, Simona Dostálová, Gabriela Věchetová, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 30, 2014
Physiotherapy for functional motor disorders: a consensus recommendationGlenn Nielsen, Jon Stone, Audrey Matthews, et al.Contemporary Clinical Trials Communications|April 3, 2023
COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plansLouise Marston, Marie Le Novere, Federico Ricciardi, et al.BJA Open|June 8, 2026
How hyperoxia affects systemic redox state: insights from PULSE-Ox, a randomised double-blind mechanistic feasibility trialAndrew F Cumpstey, Anna D Clark, Magdalena Minnion, et al.BMJ Open|July 1, 2022
Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnershipChristina Maria van der Feltz-Cornelis, Jennifer Sweetman, Mark Edwards, et al.Pageof 28